Nephrology
Conference Coverage
Biomarkers for measuring lupus nephritis treatment response gain ground
A panel of protein biomarkers in urine could achieve better identification of lupus nephritis patients who are likely to respond to treatment.
News
FDA fast tracks potential CAR T-cell therapy for lupus
The cellular therapy depletes CD19-positive B cells with the goal of ‘‘resetting’’ the immune system to achieve durable remission.
Conference Coverage
UTI imaging falls short in some primary care settings
“The authors also showed that older providers and those working in smaller practices are less likely to comply with this particular imaging...
News
Experts outline comprehensive preeclampsia prevention strategy
The report recommends at-home hypertension checks, daily aspirin, surveillance, patient and provider education, long-term follow-up, and...
Case Reports
High-Grade Staphylococcus lugdunensis Bacteremia in a Patient on Home Hemodialysis
Staphylococcus lugdunensis (S lugdunensis) is a species of coagulase-negative Staphylococcus (CoNS...
Program Profile
VA-Based Peritoneal Dialysis Program Feasibility Considerations and Process Outline
Compared with hemodialysis (HD), peritoneal dialysis (PD) offers comparable survival and superior patient-centered and...
Latest News
SGLT2 inhibitors: Real-world data show benefits outweigh risks
“The importance of our paper is that it quantifies the absolute rate of events among routine care patients and may be used to inform shared...
News
Experts share early details prescribing avacopan for ANCA-associated vasculitis
Rheumatologists said more data are needed to determine optimal glucocorticoid tapering and treatment duration of avacopan for patients with ANCA-...
News
Can SGLT2 inhibitors limit acute kidney injury in type 2 diabetes?
Contrary to the initial concerns that SGLT2 inhibitors might increase the risk of acute kidney injury, new data indicate that this complication is...
News
Experts share real-world experience prescribing voclosporin, belimumab for lupus nephritis
While some rheumatologists expressed a treatment preference, patients with lupus nephritis tend to do well on both medications; however, cost and...